MedPath

OMICO

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients

Phase 2
Recruiting
Conditions
Solid Tumor, Adult
Interventions
First Posted Date
2023-08-22
Last Posted Date
2024-11-15
Lead Sponsor
Omico
Target Recruit Count
96
Registration Number
NCT06003621
Locations
🇦🇺

Border Medical Oncology Research Unit, Albury, New South Wales, Australia

🇦🇺

Ramsay Health Care Australia Pty Ltd trading as The Border Cancer Hospital, Albury, New South Wales, Australia

🇦🇺

Coffs Harbour Health Campus, Coffs Harbour, New South Wales, Australia

and more 10 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.